Clinical Horizons NZ Ltd
Tauranga, New Zealand
Medical office in Tauranga
418A Devonport Road, Tauranga South, Tauranga 3112
About Clinical Horizons NZ Ltd
"A Clinical research unit delivering reliable data for sponsors and quality care for participants."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
4
Regeneron Pharmaceuticals
1
Clinical Trials at Clinical Horizons NZ Ltd
During the past decade, Clinical Horizons NZ Ltd conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 5 clinical trials were completed, i.e. on
average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee
2015-07-21
2019-02-27
Completed
3,021
Long-term Observational Study of Subjects From Tanezumab Studies Who Undergo a Total Knee, Hip or Shoulder Replacement
2016-08-23
2019-07-15
Completed
154
Study of Evinacumab (REGN1500) in Participants With Persistent Hypercholesterolemia
2017-11-10
2020-12-14
Completed
272
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Horizons NZ Ltd"
#1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Clinical Horizons NZ Ltd
According to Clinical.Site data, the most researched conditions in "Clinical Horizons NZ Ltd" are
"Cardiovascular Disease" (2 trials), "Chronic Pain" (1 trials), "Hypercholesterolemia" (1 trials), "Osteoarthritis" (1 trials) and "Osteoarthritis, Hip" (1 trials). Many other conditions were trialed in "Clinical Horizons NZ Ltd" in a lesser frequency.
Clinical Trials Intervention Types at Clinical Horizons NZ Ltd
Most popular intervention types in "Clinical Horizons NZ Ltd" are "Drug" (5 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "bococizumab (PF-04950615)" (2 trials), "Background Lipid Modifying Therapy (LMT)" (1 trials), "Evinacumab" (1 trials) and "Investigational Medical Product (IMP) administered in parent study" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Clinical Horizons NZ Ltd
The vast majority of trials in "Clinical Horizons NZ Ltd" are
5 trials for "All" genders.
Clinical Trials Status at Clinical Horizons NZ Ltd
Currently, there are NaN active trials in "Clinical Horizons NZ Ltd".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Clinical Horizons NZ Ltd,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Clinical Horizons NZ Ltd, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".